Table 1.
Gene | Associated neurodegenerative disease(s) | Number of models | Total (out of 147) (%) |
---|---|---|---|
APP | AD | 60 | 40.8 |
PSEN1 | AD | 27 | 18.4 |
MAPT | FTLD/PSP/CBD | 24 | 16.3 |
TARDP | ALS/FTLD | 14 | 9.5 |
APOE | AD | 10 | 6.8 |
PSEN2 | AD | 7 | 4.8 |
BACE1 | AD | 5 | 3.4 |
FUS | ALS/FTLD | 5 | 3.4 |
SOD1 | ALS | 4 | 2.7 |
C9ORF | ALS/FTLD | 3 | 2.0 |
Groups are not mutually exclusive.
AD, Alzheimer’s disease; FTLD, frontotemporal lobar degeneration; PSP, progressive supranuclear palsy; CBD, corticobasal degeneration; ALS, amyotrophic lateral sclerosis.